ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 296

A Brazilian Multicenter Study of 71 Children and Adolescents with Takayasu’s Arteritis

Maria Teresa Terreri1, Gleice Clemente2, Clovis Silva3, Silvana Sacchetti4, Adriana M. Sallum5, Lucia M. A. Campos6, Maria Carolina Santos4, Flavio Sztajnbok7, Rozana Gasparello de Almeida8, Virginia P. Ferriani9, Blanca E. Bica10, Teresa Robazzi11, Marcia Bandeira12, Andre Cavalcanti13, Marise Lessa14, Sheila K. Feitosa de Oliveira15 and Maria Odete Hilario16, 1Pediatrics, Universidade Federal de São Paulo / UNIFESP, Sao Paulo, Brazil, 2Pediatrics, Universidade Federal de São Paulo/UNIFESP, São Paulo, Brazil, 3Pediatric Rheumatology, MD; PhD, São Paulo-SP, Brazil, 4Pediatrics, Santa Casa de Misericórdia de São Paulo, São Paulo, Brazil, 5Pediatric Rheumatology Unit, Faculdade de Medicina da Universidade de São Paulo (FMUSP), São Paulo-SP, Brazil, 6Pediatric Rheumatology, University of São Paulo Medical School, São Paulo, Brazil, 7PRINTO, Genoa, Italy, 8Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil, 9Pediatrics, FMUSP-Ribeirao Preto, Ribeirao Preto, Brazil, 10International Investigator Consortium for MAS Diagnostic Criteria, Rio de Janeiro, Brazil, 11Pediatrics, Universidade Federal da Bahia, Salvador, Brazil, 12Pediatrics, Hospital Infantil Pequeno Príncipe, Curitiba, Brazil, 13Universidade Federal de Pernambuco, Recife, Brazil, 14Pediatrics, Instituto de Pediatria e Puericultura Martagão Gesteira (IPPMG) da Universidade Federal do Rio de Janeiro (UFRJ), Rio de Janeiro, Brazil, 15Pediatric Rheumatology, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil, 16Pediatrics, Universidade Federal de Sao Paulo / UNIFESP, Sao Paulo, Brazil

Meeting: 2012 ACR/ARHP Annual Meeting

Keywords: Adolescent patients, Clinical, pediatrics and vasculitis, Takayasu.s arteritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Pediatric Rheumatology - Clinical and Therapeutic Aspects: Pediatric Systemic Lupus Erythematosus, Pediatric Vasculitis and Pediatric Myositis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Takayasu’s arteritis is a chronic granulomatous disease that affects the vascular wall of the large arteries and can result in end organ damage. It is more prevalent in young women, but can also occur in the childhood. The disease is rare and there are few reports about the clinical features at this age. Our aim was to describe the clinical features of Takayasu’s arteritis in children and adolescents in our population.

Methods: In this Brazilian multicenter retrospective study including 10 pediatric rheumatology centers we identified 71 children and adolescents with Takayasu’s arteritis. Patients’ demographic, clinical, laboratory, angiographic, therapeutic data and disease outcome were recorded.

Results: Of the 71 patients, 51 (72%) were girls, with a mean age at onset of 9.2 years (range 4 months to 17.2 years); the average time to diagnosis was 1.2 years; and the mean follow-up time was 5.4 years., The most frequent angiographic type was type IV (41%) followed by type V (27%) and the abdominal aorta was the most affected vessel (63.4%). The main lesion was arterial stenosis (84.5% of patients). At initial presentation 80.6% of patients had increased acute phase reactants and 41% of patients had a positive Mantoux test. The predominant clinical symptoms at onset were constitutional (77.5%), followed by neurological (70.4%) and musculoskeletal symptoms (64.8%). The main cardiovascular manifestation was arterial hypertension (84.5%). At the final evaluation, neurological symptoms were predominant (22.7%) and decrease of peripheral pulses (66.7%) was the main cardiovascular manifestation. Sixty four (90.1%) patients were treated with corticosteroids, 30 patients (42.3%) with methotrexate as the first immunosuppressive treatment and 18 (25.4%) were treated with cyclophosphamide as initial therapy. Infliximab was used in only 4 patients throughout the follow-up. At the final evaluation, 55% of patients were in disease remission, 28% had active disease, 7% died and in 10% the outcome was unknown.

Conclusion: Takayasu’s arteritis is a rare childhood disease. In this multicenter study we observed a high rate of disease remission, however prospective studies are needed in order to better define overall disease outcome.


Disclosure:

M. T. Terreri,
None;

G. Clemente,
None;

C. Silva,
None;

S. Sacchetti,
None;

A. M. Sallum,
None;

L. M. A. Campos,
None;

M. C. Santos,
None;

F. Sztajnbok,
None;

R. Gasparello de Almeida,
None;

V. P. Ferriani,
None;

B. E. Bica,
None;

T. Robazzi,
None;

M. Bandeira,
None;

A. Cavalcanti,
None;

M. Lessa,
None;

S. K. Feitosa de Oliveira,

Novartis Pharmaceutical Corporation,

2,

Roche Pharmaceuticals,

2,

Bristol-Myers Squibb,

2;

M. O. Hilario,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2012 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/a-brazilian-multicenter-study-of-71-children-and-adolescents-with-takayasus-arteritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology